IE36653L - 17 - hydroxy - 7 (alkoxy) carbonyl - 3 - oxo - 17ó - pregn -¹4 - ene - 21 - carboxylic acid.ô-lactones. - Google Patents
17 - hydroxy - 7 (alkoxy) carbonyl - 3 - oxo - 17ó - pregn -¹4 - ene - 21 - carboxylic acid.ô-lactones.Info
- Publication number
- IE36653L IE36653L IE721160A IE116072A IE36653L IE 36653 L IE36653 L IE 36653L IE 721160 A IE721160 A IE 721160A IE 116072 A IE116072 A IE 116072A IE 36653 L IE36653 L IE 36653L
- Authority
- IE
- Ireland
- Prior art keywords
- compound
- alkyl
- give
- contacting
- carboxylic acid
- Prior art date
Links
- 125000003545 alkoxy group Chemical group 0.000 title 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 16
- 125000000217 alkyl group Chemical group 0.000 abstract 11
- 229910052783 alkali metal Inorganic materials 0.000 abstract 5
- -1 alkali metal alkoxide Chemical class 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 150000001340 alkali metals Chemical class 0.000 abstract 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 3
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 3
- 239000011707 mineral Substances 0.000 abstract 3
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 abstract 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 238000010306 acid treatment Methods 0.000 abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 2
- 239000002585 base Substances 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 229910052751 metal Inorganic materials 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- 239000007858 starting material Substances 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- UJVLDDZCTMKXJK-WNHSNXHDSA-N canrenone Chemical compound C([C@H]1[C@H]2[C@@H]([C@]3(CCC(=O)C=C3C=C2)C)CC[C@@]11C)C[C@@]11CCC(=O)O1 UJVLDDZCTMKXJK-WNHSNXHDSA-N 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1368005 7-Carboxy steroids and related compounds G D SEARLE & CO 24 Aug 1972 [25 Aug 1971] 39401/72 Heading C2U Novel steroids have the formulµ wherein Z is H, alkali metal, alkaline earth metal/2, ammonium or alkyl; Z<SP>1</SP> is H, alkali metal, alkaline earth metal/2 or ammonium when Z is alkyl and is identical to Z when Z is H, alkali metal, alkaline-earth metal/2 or ammonium; the #<SP>1</SP> double bond is optional; the wavy line indicates the alternative α and # configurations; and X is oxygen, and it may also be sulphur when Z is alkyl and #<SP>1</SP> is absent in (Ia). They are prepared by (a) contacting 4α,7α - carbonyl - 5 - cyano - 17 - hydroxy - 3- oxo - 5#,17α - pregnane - 21 - carboxylic acid γ-lactone with an alkali metal alkoxide to afford a mixture of 7α and 7# compounds (Ia) wherein X is O, Z is alkyl and #<SP>1</SP> is absent, which may be separated by conventional procedures; (b) contacting an active acylating derivative of a compound (Ia) wherein X is O and Z is H, particularly a novel compound of the formula with an alkanol to give compounds (Ia) wherein X is O and Z is alkyl, the acylating derivatives (II) being prepared from the corresponding 7- carboxylic acids (Ia) and alkyl chloroformates in the presence of a tertiary amine; (c) dehydrogenating a compound (Ia) wherein X is O, Z is alkyl and #<SP>1</SP> is absent to give the corresponding #<SP>1,4</SP> compound, using, for example, 2,3-dichloro - 5,6 - dicyano - 1,4 - benzoquinone; (d) reacting a compound (Ia) wherein X is O and Z is alkyl or H with, respectively, one or two equivalents of a base, e.g. KOH, in an aqueous medium, to give the corresponding mono- or bis-metal salt (Ib) followed, when required, by brief exposure to a proton source to give the corresponding mono- or di-carboxylic acid (Ib); (e) hydrolysing under alkaline conditions a compound (Ia) wherein X is O and Z is alkyl followed by mineral acid treatment to give a compound (Ia) wherein X is O and Z is H; (f) contacting a starting material as defined in (b) above with an alkane thiol to give a compound (Ia) wherein X is S, Z is alkyl and #<SP>1</SP> is absent; (g) contacting a starting material as defined in (a) above with KOH in methanol followed by alkaline hydrolysis and subsequent mineral acid treatment to give a corresponding 7α compound (Ia) wherein X is O, Z is H and #<SP>1</SP> is absent; (h) contacting a compound (Ia) or (Ib) wherein X is O, Z is H or alkyl and Z<SP>1</SP> is H which contains at least one acid hydrogen with an appropriate quantity of a base in an aqueous medium to give a corresponding mono- or bis-metal salt of a compound (Ia) or (Ib); or (i) contacting a compound (Ia) wherein X is O and Z is H or a compound (Ib) wherein X is O, Z is H or alkyl and Z<SP>1</SP> is H with excess ammonia to give a corresponding ammonium salt. 4α,7α - Carbonyl - 5 - cyano - 17 - hydroxy - 3- oxo - 5#,17α - pregnane - 21 - carboxylic acid γ-lactone is prepared by heating 17-hydroxy-3- oxo - 17α - pregna - 4,6 - diene - 21 - carboxylic acid γ-lactone with an alkali metal cyanide under slightly basic conditions in a solvent followed by heating the resulting 7α,4-aminomethylidyne - 5 - cyano - 17 - hydroxy - 3 - oxo- 5#,17α - pregnane - 21 - carboxylic acid γ- lactone with very dilute aqueous mineral acid (see Specification 1,368,006). The novel steroids of the Formulµ (Ia) and (Ib) are diuretic and blood pressure-lowering agents. They may be made up into pharmaceutical compositions with suitable carriers.
[GB1368005A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17492271A | 1971-08-25 | 1971-08-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE36653L true IE36653L (en) | 1973-02-25 |
IE36653B1 IE36653B1 (en) | 1977-01-19 |
Family
ID=22638078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1160/72A IE36653B1 (en) | 1971-08-25 | 1972-08-24 | 17-hydroxy-7-(lower alkoxy) carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acidgamma-lactones and congeners |
Country Status (21)
Country | Link |
---|---|
JP (2) | JPS5839840B2 (en) |
AT (1) | AT323907B (en) |
AU (1) | AU475957B2 (en) |
BE (1) | BE787940A (en) |
CA (1) | CA970361A (en) |
CH (2) | CH601350A5 (en) |
DE (1) | DE2241680C2 (en) |
DK (1) | DK133954B (en) |
ES (2) | ES406044A1 (en) |
FI (1) | FI50429C (en) |
FR (1) | FR2150852B1 (en) |
GB (1) | GB1368005A (en) |
IE (1) | IE36653B1 (en) |
IL (1) | IL40197A (en) |
KE (1) | KE2813A (en) |
MY (1) | MY7800121A (en) |
NL (1) | NL176569C (en) |
NO (1) | NO134990C (en) |
PH (1) | PH9271A (en) |
SE (2) | SE380533B (en) |
ZA (1) | ZA725839B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069219A (en) * | 1976-12-27 | 1978-01-17 | G. D. Searle & Co. | 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters |
FR2496669A1 (en) * | 1980-12-23 | 1982-06-25 | Roussel Uclaf | NOVEL STEROID 3-KETO4 OR 1-4 SUBSTITUTED DERIVATIVES IN POSITION 7, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS |
DE3111951A1 (en) * | 1981-03-23 | 1982-09-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 7 (ALPHA) -ALKOXYCARBONYL-15SS-METHYLENE-4-ANDROSTENE, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICINAL PRODUCT |
JPS57169230A (en) * | 1981-04-10 | 1982-10-18 | Matsushita Electric Ind Co Ltd | Oil-immersed plastic ilm capacitor |
US5296318A (en) * | 1993-03-05 | 1994-03-22 | Bell Communications Research, Inc. | Rechargeable lithium intercalation battery with hybrid polymeric electrolyte |
BRPI0515106A (en) * | 2004-09-09 | 2008-07-08 | Pharmacia Corp | process for preparing substituted 7 (alpha) -alkoxycarbonyl steroids |
-
0
- BE BE787940D patent/BE787940A/en not_active IP Right Cessation
-
1972
- 1972-08-21 AU AU45787/72A patent/AU475957B2/en not_active Expired
- 1972-08-23 ES ES406044A patent/ES406044A1/en not_active Expired
- 1972-08-24 PH PH13830*UA patent/PH9271A/en unknown
- 1972-08-24 AT AT733172A patent/AT323907B/en not_active IP Right Cessation
- 1972-08-24 FR FR7230235A patent/FR2150852B1/fr not_active Expired
- 1972-08-24 IL IL40197A patent/IL40197A/en unknown
- 1972-08-24 CA CA150,118A patent/CA970361A/en not_active Expired
- 1972-08-24 GB GB3940172A patent/GB1368005A/en not_active Expired
- 1972-08-24 FI FI722353A patent/FI50429C/en active
- 1972-08-24 NL NLAANVRAGE7211559,A patent/NL176569C/en not_active IP Right Cessation
- 1972-08-24 SE SE7210976A patent/SE380533B/en unknown
- 1972-08-24 DK DK420472AA patent/DK133954B/en not_active IP Right Cessation
- 1972-08-24 IE IE1160/72A patent/IE36653B1/en unknown
- 1972-08-24 NO NO3032/72A patent/NO134990C/no unknown
- 1972-08-24 DE DE2241680A patent/DE2241680C2/en not_active Expired
- 1972-08-24 ZA ZA725839A patent/ZA725839B/en unknown
- 1972-08-25 JP JP47085217A patent/JPS5839840B2/en not_active Expired
- 1972-08-25 CH CH1262572A patent/CH601350A5/xx not_active IP Right Cessation
-
1974
- 1974-12-04 SE SE7415187A patent/SE404024B/en unknown
-
1975
- 1975-02-28 ES ES435189A patent/ES435189A1/en not_active Expired
-
1977
- 1977-03-25 CH CH383477A patent/CH603689A5/xx not_active IP Right Cessation
-
1978
- 1978-01-19 KE KE2813A patent/KE2813A/en unknown
- 1978-12-30 MY MY121/78A patent/MY7800121A/en unknown
-
1982
- 1982-10-29 JP JP57190666A patent/JPS5890598A/en active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE36653L (en) | 17 - hydroxy - 7 (alkoxy) carbonyl - 3 - oxo - 17ó - pregn -¹4 - ene - 21 - carboxylic acid.ô-lactones. | |
GB1389621A (en) | Salts of 3-hydroxy-2-hydroxy-methyl-propanesulphonic acid-1 and a process for their preparation | |
GB1384471A (en) | Process for the manufacture of fatty acid ethanolamides | |
GB1371688A (en) | Process for preparing benzoxazolones-2- and benzothiazolones-2 | |
GB1368006A (en) | 4alpha,7alpha-carbonyl-5-cyano-17-hzydroxy-3-oxo-5beta,17alpha- pregnane-21-carboxylic acid ypsilon-lactone | |
GB1455220A (en) | ||
GB1355991A (en) | Unsaturated chemical compounds | |
GB1496169A (en) | Stabilized polyglycol for high temperatures | |
GB1417808A (en) | 7a-cyano-17-hydroxy-3-oxo-17a-pregn-4-ene-21-carboxylic acid ypsilon-lactone and related compounds | |
GB1474142A (en) | Lactone | |
GB1380952A (en) | Cholestane derivatives and processes for their preparation | |
GB1130052A (en) | Improvements in or relating to steroids and intermediates for the production thereof | |
GB1397434A (en) | Evomonoside derivatives | |
FR2275455A1 (en) | D-Hydroxyalkyl desoxyvincaminates - by hydrogenation of 2-oxoalkyl desoxyvincaminates and the corresp. apovincaminates (NO190176) | |
GB1449914A (en) | 2,2, 10beta, 17 alpha-tetramethyl steroids a process for their preparation and compositions containing them | |
GB1421555A (en) | Process for the stereoselective production of intermediates in the synthesis of pge1 and derivatives | |
GB1423028A (en) | Acid calcium cis-epoxy-succinate and its production | |
GB661537A (en) | Improvements in and relating to the preparation of sulphonyl derivatives of piperazine | |
GB1466411A (en) | Sulphur-containing hydroxy aliphatic compounds | |
GB1133713A (en) | í¸-3-oxo-steroids | |
GB1512543A (en) | Cholestane derivatives and their preparation | |
GB1450693A (en) | Beta-3-oxo-7alpha-acylthio-17beta-hydroxy-4-androsten-or estren- 17alpha-yl- propionic acidderivatives | |
GB1388443A (en) | Selective reduction of 9,15-dioxoprostanoic acids | |
JPS5272883A (en) | Preparation of sulfur-containing amino acid | |
JPS5569563A (en) | Preparation of 2-methoxy-5-sulfamoylbenzoic acid amide |